Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies.
ACS Med Chem Lett
; 11(12): 2374-2381, 2020 Dec 10.
Article
in En
| MEDLINE
| ID: mdl-33335659
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Med Chem Lett
Year:
2020
Document type:
Article